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OBJECTIVES To develop and validate simple statistical models that can be used with hospital discharge
administrative databases to predict 30-day and one-year mortality after an acute myocardial
infarction (AMI).
BACKGROUND There is increasing interest in developing AMI “report cards” using population-based hospital
discharge databases. However, there is a lack of simple statistical models that can be used to
adjust for regional and interinstitutional differences in patient case-mix.
METHODS We used linked administrative databases on 52,616 patients having an AMI in Ontario,
Canada, between 1994 and 1997 to develop logistic regression statistical models to predict
30-day and one-year mortality after an AMI. These models were subsequently validated in
two external cohorts of AMI patients derived from administrative datasets from Manitoba,
Canada, and California, U.S.
RESULTS The 11-variable Ontario AMI mortality prediction rules accurately predicted mortality with
an area under the receiver operating characteristic (ROC) curve of 0.78 for 30-day mortality
and 0.79 for one-year mortality in the Ontario dataset from which they were derived. In an
independent validation dataset of 4,836 AMI patients from Manitoba, the ROC areas were
0.77 and 0.78, respectively. In a second validation dataset of 112,234 AMI patients from
California, the ROC areas were 0.77 and 0.78 respectively.
CONCLUSIONS The Ontario AMI mortality prediction rules predict quite accurately 30-day and one-year
mortality after an AMI in linked hospital discharge databases of AMI patients from Ontario,
Manitoba and California. These models may also be useful to outcomes and quality
measurement researchers in other jurisdictions. (J Am Coll Cardiol 2001;37:992–7) © 2001
by the American College of Cardiology
Because management of coronary disease affects millions of
patients worldwide, the assessment of the outcomes of acute
myocardial infarction (AMI) using population-based hos-
pital discharge data bases is an important activity. AMI
“report cards” listing hospital-specific rates have been pub-
licly released in several U.S. states and some countries in
Europe (1–4). However, to properly conduct these studies,
an appropriate statistical model must be developed to adjust
See page 998
for patient case-mix differences between institutions. A few
statistical models that have already been implemented using
administrative databases to predict AMI mortality are not
widely used because they require many variables and com-
plex models and often have not been validated in other
jurisdictions (3,5,6).
In Ontario, we published the first hospital-specific AMI
“report card” in Canada in 1999 (7). This report contained
information on the 30-day and one-year risk-adjusted
mortality rates for 52,616 AMI patients at 167 hospitals in
Ontario between April 1, 1994, and March 31, 1997. As
part of the development of the Ontario AMI report, we
created a simple 11-variable prediction rule using the
secondary diagnosis fields in the Ontario hospital discharge
data bases to adjust for regional and interinstitutional
differences in AMI case mix. To evaluate the potential
usefulness of this model to clinicians and researchers in
other jurisdictions, we tested the model in two completely
independent datasets of AMI patients in another Canadian
province, Manitoba, and a large area of the U.S., the state of
California. This study describes the derivation and valida-
tion of the “Ontario AMI mortality prediction rules.”
METHODS
Data sources. The Ontario data for the study were taken
from the Ontario Myocardial Infarction Database (OMID),
which links together all of Ontario’s major health care
administrative databases to create a large database for
monitoring the quality of AMI care in Ontario. For the
present study, we linked data on all patients discharged
with a most responsible diagnosis of an AMI (Interna-
tional Classification of Diseases [ICD]-9 code 410) in
Ontario between fiscal year 1994 and 1996 (April 1, 1994,
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to March 31, 1997). The index hospitalization data were
obtained from the Canadian Institute for Health Informa-
tion hospital discharge database while long-term follow-up
data were obtained through the Ontario Registered Persons
Database, which records the vital status of all Ontario
residents. The Ontario discharge data contain 15 secondary
diagnosis fields coded using the ICD ninth revision codes
and 15 corresponding diagnosis type indicators that indicate
whether a diagnosis is a preexisting comorbidity or a
complication (Type II diagnosis) occurring after hospital
admission. Only diagnoses coded as comorbidities were
used in the present study.
Two independent cohorts of AMI patients were created
using similar methods from administrative databases in
Manitoba at the Manitoba Centre for Health Care Policy
and Evaluation, and in California from the California Office
of Statewide Health Planning and Development hospital
discharge database.
In the California dataset, the “most responsible diagno-
sis” is specified as the “principal” diagnosis, and secondary
diagnosis codes do not distinguish between complications
and comorbid conditions.
Inclusion/exclusion criteria. Similar inclusion/exclusion
criteria were used to create the linked AMI datasets in the
three jurisdictions. Patients were included in the AMI
cohorts if they were admitted with a “most responsible”
diagnosis (ICD-9 code 410) of AMI in Ontario or Mani-
toba, or a “principal” diagnosis of AMI in California.
Previous studies have shown the similarities of these two
types of diagnoses (8). The exclusion criteria included
patients admitted to a noncardiac surgical service, those
admitted as transfers from another acute care facility, those
admitted with an AMI in the previous year, those dis-
charged alive with a total length of stay of less than four days
and those whose AMI was coded as an in-hospital compli-
cation. Transferred patients were only counted once based
on their first admission, with subsequent admissions linked
to the first one. The rationale for these criteria are described
elsewhere (9). After these inclusion/exclusion criteria were
applied, 52,616 patients were left in the Ontario AMI
cohort. A comparable cohort was created using the Mani-
toba hospital discharge data over the same time frame and
yielded a total of 4,386 AMI patients. The California cohort
for the same time period consisted of 112,234 AMI pa-
tients.
Potential risk factors for prediction model development.
Forty-three potential candidate variables in addition to age
and gender were considered for inclusion in the AMI
mortality prediction rules (Table 1). These candidate vari-
ables were taken from a list of risk factors used to develop
previous report cards in the California Hospital Outcomes
Project and Pennsylvania Health Care Cost Containment
Council AMI “report card” projects (3,5). Each of these
comorbidities was created using appropriate ICD-9 codes
from the 15 secondary diagnosis fields in OMID. The
Ontario discharge data are based on ICD-9 codes rather
than ICD-9-CM codes used in the U.S., so the U.S. codes
were truncated. Some risk factors used in these two projects
do not have an ICD-9 coding analog (e.g., infarct subtype,
race) and therefore were not included in our analysis. The
frequency of each of these 43 comorbidities was calculated,
and any comorbidity with a prevalence of ,1% was ex-
cluded from further analysis. Comorbidities that the authors
felt were not clinically plausible predictors of AMI mortality
were also excluded. The remaining variables were then
entered into a multivariate logistic regression model and
backward stepwise regression was used to eliminate variables
until only variables significant at the p , 0.05 level were left
in the final model. The discrimination of the resulting
models was calculated by measuring the area under the
receiver operating characteristic (ROC) curve (10).
Prediction model validation. The logistic regression mod-
els were developed to predict 30-day mortality and one-year
mortality in the Ontario dataset. Separate regression coef-
ficients were fit for 30-day and one-year mortality. We also
determined the prevalence of each of the comorbidities
using the Deyo adaption of the Charlson comorbidity index
score (11) and calculated disease-specific regression coeffi-
cients for the Charlson comorbidities so that we could
compare the predictive performance of the Charlson model
with those in the Ontario AMI mortality prediction rules.
The resulting coefficients from the Ontario models were
then applied in the independent Manitoba and California
AMI datasets to evaluate the generalizability of the models.
The areas under the ROC curves were compared in both the
derivation and validation datasets. The calibration of the
model was assessed by comparing the mean observed and
predicted 30-day AMI mortality rates among patients
sorted into deciles of ascending risk. All statistical analyses
were conducted using SAS version 6.12 (SAS Institute Inc.,
Cary, North Carolina).
RESULTS
Prevalence of risk factors. A list of the final 11 variables in
the Ontario AMI mortality prediction rules is shown in
Table 2 along with the ICD-9 codes used to generate them.
The corresponding 30-day and one-year mortality rates for
each of these risk factors is also presented. These results
show that congestive heart failure was the most common
comorbidity, followed by cardiac dysrhythmias. The pres-
ence of shock was associated with the highest one-year
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
ICD 5 International Classification of Diseases
OMID 5 Ontario Myocardial Infarction Database
OR 5 odds ratio
ROC 5 receiver operating characteristic
TECH 5 Technological Change in Health Care
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mortality rate (82.7%) followed by acute renal failure
(70.4%). All of these variables were significant in the
univariate analyses for both 30-day and one-year mortality
at the p , 0.001 level.
The overall 30-day mortality rate in the Ontario AMI
patients was 14.8% and the one-year mortality rate was
23.2%.
Regression coefficients. Table 3 shows the logistic regres-
sion coefficients and associated odds ratio (OR) with 95%
confidence intervals for both the 30-day and one-year
mortality prediction rules. The presence of shock at hospital
admission was the strongest predictor of mortality at 30 days
(OR 5 22.31, 95% CI, 19.30 to 25.79) followed by age .75
years (OR 5 12.24, 95% CI, 10.18 to 14.71).
Model performance. In the Ontario derivation set, both
the 30-day and one-year mortality prediction rules per-
formed well with areas under the ROC curve of 0.78 and
0.79, respectively (Table 4). In comparison, a disease-
specific Charlson comorbidity index score yielded an ROC
area of 0.74 and 0.77 respectively.
Figure 1 shows an assessment of the calibration charac-
teristics of the model. There is a high correlation (R2 5
0.985) between the predicted and observed 30-day AMI
mortality rates within each decile of patient risk.
The performance of the models in the independent
California and Manitoba datasets is shown in Table 4. The
models predicted well in these datasets, with areas under the
ROC curve of 0.77 for 30-day mortality and 0.78 for
one-year mortality in both regions. In contrast, the Charl-
son comorbidity index validated less well in the two external
cohorts of AMI patients. We also recalibrated each of the
models to develop Manitoba- and California-specific re-
gression coefficients and found that the ORs were similar
for each of the 11 variables in the Ontario mortality
prediction rules (data not shown).
DISCUSSION
Hospital report cards have been published in several juris-
dictions in North America and are likely to become increas-
ingly prevalent in the 21st century as the public demand for
information on health care increases. Acute myocardial
infarction is likely to be a focus of many of these reports
because it is a very common and highly lethal condition for
which there are many effective therapies that lower short-
term mortality rates. A simple risk-adjustment model that
could be easily generated using administrative databases
would be very useful, as it would allow researchers to
conduct risk-adjusted outcome analyses across and within
jurisdictions. In this study, we developed and validated a
Table 1. Clinical Risk Factors Studied as Possible Predictors of Mortality After an AMI
California Hospital Outcomes Project*
Pennsylvania Health Care Cost
Containment Council†
Aspiration pneumonia Cardiac dysrhythmias
Catastrophic sequelae of AMI Premature beats
Central nervous system disease Cardiac dysrhythmia, unspecified
Cerebrovascular disease, other Other specified cardiac dysrhythmias
Coma Paroxysmal tachycardia
Complete AV block Atrial fibrillation and/or flutter
Congestive heart failure Ventricular fibrillation and/or flutter
Diabetes, complicated Cardiogenic shock
High risk or secondary malignant neoplasm Cardiomyopathy
Hypertension Conduction disorders
Ischemic bowel or liver Left bundle branch hemiblock/other left bundle
Paroxysmal ventricular tachycardia branch block
Prior coronary artery bypass graft AV block, other and unspecified
Pulmonary edema Right bundle branch block; bundle branch
Renal failure, acute or unspecified block, other and unspecified; other heart block
Renal failure, chronic Unspecified conduction disorder
Seizure disorder AV block, complete
Sepsis Other specified conduction disorders
Shock Diabetes
Thyroid disease Diabetes without complications
Diabetes with complications
Dialysis
Heart failure
Hypertension with complications
Hypertension without complications
Malignant neoplasm
Prior CABG surgery
Renal failure
*Obtained from the Office of Statewide Health Planning and Development, California Hospital Outcomes Project 1997. Report
on Heart Attack 1991–1993, Technical Guide (vol. 2). †Obtained from the Pennsylvania Health Care Cost Containment
Council, Focus on Heart Attack Report, 1996.
AV 5 atrioventricular; CABG 5 coronary artery bypass graft.
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simple 11-variable model to predict short- and long-term
mortality after an AMI. The model performed well not only
in the Ontario AMI patient population from which it was
derived, but also in two completely independent cohorts of
AMI patients from California and Manitoba.
Other AMI prediction rules. Several prediction rules have
been developed by other investigators to predict AMI
mortality using administrative databases. However, each of
these models has a number of limitations. Normand et al.
(6) developed a 40-variable prediction rule using the U.S.
Medicare claims database. However, the performance of
this model was only 0.72 in terms of its ROC curve area for
two-year mortality in the dataset from which it was derived.
The developers of the Pennsylvania and California report
cards have also developed prediction rules using their
administrative databases. However, in both jurisdictions
two separate models are required. The Pennsylvania group
requires one model for direct admissions and a separate
model for transferred-in patients (3). For the California
report card, separate models were developed for patients
with no prior hospital admissions versus those with prior
hospital admissions (5). In contrast, the Ontario AMI
mortality prediction rules can be applied to all AMI patients
and predict both 30-day and one-year mortality after an
AMI using the same set of predictor variables.
Clinical prediction rules. Although AMI outcome predic-
tion rules developed using clinical data remain the ultimate
“gold standard” for risk adjustment, it is very expensive and
time-consuming to collect these data on a population basis.
For these reasons, it is likely that most report cards on AMI
care will continue to be developed using routinely collected
hospital discharge databases. A recent study using data
abstracted from the charts of elderly AMI patients in the
U.S. Cardiovascular Cooperative Project yielded a predic-
Table 2. Risk Factors Included in the Ontario Acute Myocardial Infarction Mortality
Prediction Rules
Risk Factor
International Classification
of Diseases
9th Revision Code
Prevalence
(%)
30-Day
Mortality
(%)
One-Year
Mortality
(%)
Age
50–64 — 27.2 5.7 9.3
65–74 — 28.9 13.9 22.2
751 — 32.8 27.3 42
Female — 36.9 19.3 29.7
Shock 785.5 2.5 78.6 82.7
Diabetes with complications 250.1–250.9 2.0 21.8 40.3
Congestive heart failure 428.x 20.7 24.7 43.4
Cancer 140.0–208.9 1.9 29.6 54.7
Cerebrovascular disease 430.0–438.x 4.1 30.9 46.6
Pulmonary edema 518.4, 514.x 1.3 30.1 47.2
Acute renal failure 584.x, 586.x, 788.5 1.5 53.2 70.4
Chronic renal failure 585.x, 403.x, 404.x, 996.7, v451 2.4 28.0 52.5
Cardiac dysrhythmias 427.x 14.7 21.8 33.3
Overall 14.8 23.2
All data are based on the 52,616 patients in the Ontario AMI cohort.
Table 3. Logistic Regression Models for Predicting 30-Day and One-Year Mortality After an Acute Myocardial Infarction in
Ontario, 1994/95–1996/97
30-Day
Regression
Coefficient
Odds
Ratio
95%
Confidence
Interval
One-Year
Regression
Coefficient
Odds
Ratio
95%
Confidence
Interval
Age*
50–64 0.8811 2.41 1.99–2.93 0.9412 2.56 2.19–3.00
65–74 1.7217 5.59 4.65–6.74 1.7846 5.96 5.12–6.93
751 2.5045 12.24 10.18–14.71 2.6226 13.77 11.86–16.00
Female 0.1607 1.17 1.11–1.24 0.1386 1.15 1.10–1.20
Shock 3.1050 22.31 19.30–25.79 2.7540 15.71 13.43–18.37
Diabetes with complications 0.3467 1.41 1.20–1.67 0.6571 1.93 1.67–2.23
Congestive heart failure 0.3231 1.38 1.30–1.47 0.7659 2.15 2.04–2.26
Cancer 0.7279 2.07 1.78–2.40 1.3105 3.71 3.22–4.26
Cerebrovascular disease 0.6776 1.97 1.78–2.18 0.7705 2.16 1.96–2.38
Pulmonary edema 0.4272 1.53 1.27–1.85 0.6587 1.93 1.63–2.29
Acute renal failure 1.3005 3.67 3.14–4.29 1.3564 3.88 3.28–4.59
Chronic renal failure 0.3826 1.47 1.27–1.69 0.8529 2.35 2.06–2.67
Cardiac dysrhythmias 0.2858 1.33 1.24–1.42 0.2776 1.32 1.24–1.40
Intercept 24.0128 23.5965
*Reference group for odds ratio is those ,50 years of age.
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tion rule with an ROC curve area of 0.79 for 30-day
mortality (12), which is only slightly superior to that which
we were able to achieve using administrative data. Further-
more, we were also able to demonstrate that this disease-
specific prediction rule predicts 30-day AMI mortality with
a higher ROC curve area than the Charlson comorbidity
index, which is the most commonly used method of
adjusting for comorbid conditions using administrative da-
tabases (13).
Strengths and limitations of the Ontario rules. The
Ontario AMI prediction rules have several strengths. First,
they use a relatively small number of variables that can be
easily generated using the appropriate ICD-9 codes from
hospital discharge databases. The variables in the model are
clinically sensible and are similar to those found in other
studies. Second, although factors, such as blood pressure at
presentation and type of infarct, are not included in the
model, other variables in the current model (i.e., shock,
congestive heart failure) may be correlated with these factors
and contribute to the models’ overall predictive perfor-
mance. Third, the model has been externally validated in
two completely different jurisdictions from which it was
derived, which represents a rigorous test of its potential
generalizability. Fourth, the rules predict both 30-day and
one-year mortality, whereas most other models were de-
signed only to predict short-term mortality.
The Ontario AMI mortality prediction rules also have
their limitations. First, we were not able to directly compare
their predictions against those that would occur with a
prediction rule derived from clinical data. Second, it remains
to be established whether risk-adjusted mortality rates
calculated using this rule are a marker of better quality
in-hospital care (e.g., higher rates of use of aspirin, beta-
blockers, thrombolytics). These types of studies are planned
in the future.
In summary, we have developed and validated the On-
tario AMI mortality prediction rules: simple logistic regres-
sion models that predict 30-day and one-year mortality after
an AMI using variables that can be easily generated from
hospital discharge administrative databases. The models are
easy to use, have clinical sensibility and have been externally
validated. These models were recently used to generate the
first hospital-specific AMI report card in Ontario, Canada’s
largest province. They have also been recently adopted for
use in the Technological Change in Health Care (TECH)
project, which involves the comparison of AMI care using
administrative databases from 16 countries around the
world (14). We believe the models will also likely prove
useful to clinicians and outcomes researchers in other
jurisdictions around the world.
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